Clinical Trial Update: To Evaluate the Efficacy and Safety of Hearticelgram®-AMI in Patients With Acute Myocardial Infarction. [Phase 3]

View source ↗

Summary

This document reports the completion of a Phase 3 trial evaluating the efficacy and safety of Hearticelgram-AMI in patients with acute myocardial infarction.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction

Drugs mentioned

• Hearticelgram-AMI

Snippet

Sponsor: Pharmicell Co., Ltd. | Conditions: Acute Myocardial Infarction | Phase 3 | Status: COMPLETED